BioWorld

Jan. 15, 1993

View Archived Issues

FDA APPROVES ARGUS TRIALS

Read More

CIBUS TAKES REVERSE APPROACH

Read More

B7 GENE PRODUCT PRIMES KILLER T CELLS

Read More

SEC APPROVES APPLIED BIO MERGER

Read More

SCIOS NOVA SELLS RECEPTOR SCREENING BUSINESS

Read More

DELIVERING NERVE GROWTH FACTOR TO BRAIN

Read More

SANDOZ INVESTS $75M IN NEUROSCIENCES INSTITUTE

Read More

RAC OKS 'COMPASSIONATE' USE OF GENE THERAPY

Read More